HIV Drug Sales Rescue GSK's Second Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
"Stand-out" sales of Tivicay and Triumeq validate GSK's decision earlier this year to hang on to its stake in ViiV Healthcare.